High Tower Advisors, LLC Seelos Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.66 - $259.46 $9,560 - $3.76 Million	-14,486 Reduced 40.16%	21,588 $14,000
Q3 2022 Nov 09, 2022	BUY	$0.65 - $278.68 $9,417 - $4.04 Million	14,489 Added 67.13%	36,074 $37,000
Q2 2022 Aug 10, 2022	SELL	$0.51 - $0.93 $1,530 - $2,790	-3,000 Reduced 12.2%	21,585 $14,000
Q1 2022 May 12, 2022	SELL	$0.84 - $1.71 $2,732 - $5,562	-3,253 Reduced 11.69%	24,585 $21,000
Q3 2021 Nov 12, 2021	BUY	$1.69 - $2.89 $5,497 - $9,401	3,253 Added 13.23%	27,838 $67,000
Q2 2021 Aug 06, 2021	SELL	$2.64 - $6.32 $198 - $474	-75 Reduced 0.3%	24,585 $65,000
Q1 2021 May 10, 2021	BUY	$1.35 - $4.99 $2,801 - $10,354	2,075 Added 9.19%	24,660 $123,000
Q4 2020 Feb 10, 2021	BUY	$0.74 - $2.01 $2,220 - $6,029	3,000 Added 15.32%	22,585 $36,000
Q3 2020 Nov 13, 2020	BUY	$0.6 - $1.25 $0 - $1	1 Added 0.01%	19,585 $18,000
Q2 2020 Aug 10, 2020	BUY	$0.42 - $1.51 $8,225 - $29,571	19,584 New	19,584 $20,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $41.6M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.